CSBR - Champions Oncology, Inc.
Earnings Results

Champions Oncology, Inc. ( $CSBR )

Recent earnings result

  1. Champions Oncology EPS beats by $0.01, beats on revenue

Events & Presentations

Champions Oncology and PhenoVista Biosciences Announce a Strategic Partnership to provide Oncology Imaging-Based Phenotypic Assays for Preclinical Drug Development

Top Stories (CSBR)

Events & Annual meetings

Title Date Webcast
Champions Oncology and PhenoVista Biosciences Announce a Strategic Partnership to provide Oncology Imaging-Based Phenotypic Assays for Preclinical Drug Development November 15, 2019
Champions Oncology Partners with TransCure bioServices to Expand European Business and Operations July 11, 2019
Champions Oncology Reports Record Quarterly Revenue of $6.2 Million September 13, 2018
4th Annual PREDiCT Tumour Models Conference January 22-24, San Francisco CA championsoncology.com webcast
Antibody Engineering and Therapeutics 2019 December 9-13, San Diego CA championsoncology.com webcast





Champions Oncology, Inc. provides an end-to-end range of research and development solutions and services, from cell lines to modeling treatment in the clinic using PDX models, that improve the productivity of oncology drug development.


Disclaimer:

The Content is made available for informational purposes only. The Content may not be complete and may be subject to change.
The Content is provided without any warranty of any kind, either express or implied.
We have collected the events here to help investors easily find the informations they need.
These are manually collected by our researchers directly from Official IR pages and not third party sources.

Recent results

Books we are reading